M. KATHLEEN BEHRENS - 31 Mar 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Director
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
31 Mar 2022
Net transactions value
+$1,399,987
Form type
4
Filing time
04 Apr 2022, 20:10:01 UTC
Previous filing
15 Mar 2022
Next filing
13 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $0 +374 +16% $0.000000 2,646 31 Mar 2022 Direct F1
transaction IGMS Common Stock Purchase $999,994 +43,478 +38% $23.00 158,200 01 Apr 2022 See footnote F2, F3
transaction IGMS Common Stock Purchase $200,008 +8,696 +41% $23.00 29,807 01 Apr 2022 See footnote F2, F4
transaction IGMS Common Stock Purchase $199,985 +8,695 +41% $23.00 29,806 01 Apr 2022 See footnote F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy.
F2 The shares were purchased pursuant to an underwritten public offering of the Issuer's securities.
F3 The shares are held in the name of KBW 2005 Trust for which Reporting Person is the Trustee.
F4 The shares are held in the name of Non-Exempt Trust for Patrick R. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee.
F5 The shares are held in the name of Non-Exempt Trust for Shannon K. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee.